NCT00051155已完成3 期
A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of any race and either sex with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension.
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
撤回
3 期
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%Open Angle GlaucomaOcular HypertensionNCT01452009Alcon Research
已完成
3 期
A Long-term Safety Study of Once-daily TravatanGlaucoma, Open-angleOcular HypertensionNCT00051168Alcon Research502
终止
4 期
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00471068Alcon Research46
已完成
4 期
Efficacy of Changing to TRAVATAN® From Prior TherapyOcular HypertensionOpen-angle GlaucomaNCT01510145Alcon Research191
已完成
3 期
A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHSyndrome of Inappropriate Antidiuretic Hormone SecretionNCT03048747Otsuka Pharmaceutical Co., Ltd.16